Seven years ago, he was a dying man. Now the Norwegian microbiologist Paul Bild and his firm Anybio is about to get their international breakthrough – a contract with millionaire Jeffrey Hughes. Paul offers a treatment for Hughes’ sick daughter, like he himself received seven years earlier. Paul has dedicated his life to the fight against multi-resistant bacteria, and Anybio Analytics is the best analysis software on the market. He doesn’t have many customers; developing a new antibiotic is unprofitable. But bacteria are discovered that are immune to all existing medicine. Authorities offer rewards for new research. New companies are entering the market. Tom Avild travels to the branch office in Ukraine to finalize Analytics. But something is wrong, and Avild and his colleague Romanov are thrown into a world where powerful forces are fighting to win. A fight where the end justifies the means. A fight to the death.